Skip to main content

Gillheeney Gary S.'s Form 4 filing

Organogenesis Holdings Inc. (ORGO) · filed Dec 9, 2024

Accession no.
0001062993-24-020285
Filed
Dec 9, 2024
Trade date
Dec 5-9, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $211.7K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gillheeney Gary S.CIK 0001757373Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 5, 2024Class A Common StockMOption exerciseAcquired+1,067,245$0.99+$1,056,572.553,419,194Direct
Dec 6, 2024Class A Common StockSSaleDisposed−18,416$3.65−$67,218.43,400,778Direct
Dec 9, 2024Class A Common StockSSaleDisposed−41,052$3.52−$144,503.043,359,726Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 5, 2024Class A Common StockMOption exerciseDisposed−1,067,245$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)